Discover insights from Autolus Therapeutics' Q2 2025 earnings call. Explore revenue growth, AUCATZYL expansion, and strategic plans for U.S. and EU markets.

Q2 2025 net revenue of $25.9 million, driven by product net revenue of $21.8 million Completed sale of PRV for $150.0 million, bolstering the balance sheet as the Company executes on its commercial ...

Today's powerful AI models are smart enough to predict the real reaction of users to OpenAI switch to a single model, ChatGPT ...

D printing company 3D Systems (NYSE:DDD) in Q2 CY2025, with sales falling 16.3% year on year to $94.84 million. Its non-GAAP ...

Beyond being a global pop superstar, Swift is a master marketer. Here are five Swift strategies for entrepreneurs to emulate.

Grounded 2 is also a change in how Obsidian works; the studio tapped Eidos, known for its work on the modern Deus Ex games ...

While the summer months are often relatively quiet for Apple, the company still has many new products coming later this year.

Boasting a barely-there feel and colour-correcting pigment, this tinted SPF has earned pride of place in my minimal holiday ...

Humacyte shares plummeted 30% following its second-quarter earnings report. Check out what prompted me to maintain my Sell ...

Auxy Studio is one of our favourite music-making apps for iOS. Launched in 2014, it offered users a simple, uncluttered ...

Huawei Mate XT 2 is reportedly going to launch on September 10, the same day as the iPhone 17 series. This is going to be a ...

A major milestone has been achieved for the Autonomous Multi-Domain Launcher as it moves toward augmenting — and possibly ...